Incremental value of insulin resistance surrogate indices beyond the CHA₂DS₂-VASc score for predicting thromboembolic events in patients with chronic heart failure and atrial fibrillation.

Authors

Yingli Xie, Yanhui Han, You Zhou, Huifeng Zhang

Published in

Frontiers in endocrinology. Volume 17. Pages 1954348. Epub Sep 23, 2026.

Abstract

Patients with chronic heart failure (CHF) and atrial fibrillation (AF) are at high risk of thromboembolic events. Although the CHA₂DS₂-VASc score is widely used for risk stratification, it may not fully capture metabolic dysfunction. Whether insulin resistance (IR) surrogate indices provide incremental information beyond the CHA₂DS₂-VASc score in patients with CHF and AF remains unclear.
This retrospective cohort study included 4,474 patients with CHF and AF. IR surrogate indices were calculated, and thromboembolic events were defined as ischemic stroke or systemic embolism (IS/SE). Multivariable Cox regression models assessed the associations between these indices and thromboembolic risk. Their incremental value beyond the CHA₂DS₂-VASc score for 4-year IS/SE risk was evaluated using discrimination, reclassification, and clinical utility measures, with stratification by AF type.
During a median follow-up of 4.00 years, 349 IS/SE events occurred. After multivariable adjustment, the hazard ratios per 1-SD increase were 1.27 (95% confidence interval, 1.13-1.43) for the TyG index, 1.41 (1.28-1.56) for the TyG-BMI index, 1.27 (1.20-1.34) for METS-IR, and 1.13 (1.08-1.19) for the TG/HDL-C ratio (all P < 0.001). Risk increased progressively across tertiles of each index, and the associations remained consistent in competing-risk analyses. Adding METS-IR or the TyG-BMI index to the CHA₂DS₂-VASc score significantly increased the AUC from 0.637 to 0.682 and 0.673, respectively, and improved reclassification. Decision curve analysis showed greater net benefit for models incorporating IR surrogate indices, particularly METS-IR and the TyG-BMI index. The incremental predictive improvements appeared more evident in patients with non-paroxysmal AF.
IR surrogate indices were independently associated with IS/SE in patients with CHF and AF. METS-IR and the TyG-BMI index provided the most consistent incremental information beyond the CHA₂DS₂-VASc score, with more evident improvements observed in patients with non-paroxysmal AF.

PMID:
42845803
Bibliographic data and abstract were imported from PubMed on 08 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.